Par Pacific (PARR) Files Form 144 for 2,000-Share Sale via Merrill Lynch
Rhea-AI Filing Summary
Par Pacific Holdings, Inc. (PARR) filed a Form 144 reporting a proposed sale of 2,000 shares of common stock through Merrill Lynch (Atlanta). The filing lists an aggregate market value of $66,730 and an approximate sale date of 09/15/2025 on the NYSE. The shares were acquired through compensatory vesting events earlier in 2024: 1,119 shares vested on 01/05/2024 and 881 shares vested on 04/05/2024, both from Par Pacific Holdings, Inc., with payment characterized as compensatory. The filer reports no securities sold in the past three months.
Positive
- Clear disclosure of the broker (Merrill Lynch) and the approximate sale date (09/15/2025)
- Acquisition details provided showing shares were received via compensatory vesting on 01/05/2024 and 04/05/2024
- No sales in prior three months reported, which clarifies recent trading activity for the filer
Negative
- None.
Insights
TL;DR: Insider-originated sale notice for 2,000 vested shares via Merrill Lynch, scheduled for mid-September 2025; routine compliance filing.
The Form 144 documents a planned disposition of 2,000 common shares with an aggregate market value of $66,730 and an expected execution date of 09/15/2025. Acquisition details show these shares were received via compensatory stock award vesting on 01/05/2024 (1,119 shares) and 04/05/2024 (881 shares). No sales by the reporting person occurred in the prior three months, and the broker is identified as Merrill Lynch in Atlanta. This filing serves as a regulatory notice under Rule 144 and does not itself indicate whether sales will be executed or their final timing beyond the approximate date listed.
TL;DR: The filing reflects standard disclosure of an intended sale of vested, compensatory shares; it aligns with Rule 144 reporting expectations.
Details provided are limited but clear: the securities were obtained through vesting of stock awards from the issuer and will be offered through a named broker. The filer affirms there is no undisclosed material adverse information. The filing contains no allegations, covenant changes, or governance actions; it is a compliance disclosure notifying the market of a prospective insider sale.